Try our beta test site
Trial record 2 of 25 for:    Avanir

A Phase 1 Study Comparing AVP-786 With AVP-923

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Avanir Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT02336347
First received: January 8, 2015
Last updated: July 10, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)